Mihaela is a regulatory affairs professional with broad and deep experience leading pharmaceutical product regulatory affairs activities on a global basis.
Before joining Atea, Mihaela served as Senior Director of Global Regulatory Affairs and Regulatory Therapeutic Area Head covering Neurodegenerative (e.g. Alzheirmer’s) and Neuromuscular (e.g. spinal muscular atrophy) diseases at Biogen. Having started her career in the pharmaceutical industry in the EU, Mihaela pursued opportunities in the US where she held positions of increasing global responsibility with pharmaceutical companies including Vertex Pharmaceuticals, Alkermes, and Shire (now Takeda).
Mihaela holds an M.Sc. in Organic Chemistry from the Polytechnical Institute of Bucharest, Romania, and an M.Sc. in Pharmaceutical Products Development and International Registration from Université Paris-Sud, France. Dr. MacNair holds a Ph.D. in Analytical Spectrochemistry from Université Paris 7, Denis Diderot, France.Back to Full Team